1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Rare Disease Pilot Grants and Other Requests for Applications (ARISEN Pilot Research Grant) is sponsored by Rare Diseases Clinical Research Network (RDCRN) - Autoimmunity, Rasmussen's, Inflammation & Status Epilepticus research Network (ARISEN). The ARISEN network invites applications for pilot research projects that accelerate clinical research in rare diseases aligned with the consortium's mission.
While focused on autoimmune encephalitis, Rasmussen syndrome, and NORSE/FIRES, research into related rare diseases with similar underlying mechanisms might be considered.
Get alerted about grants like this
Save a search for “Rare Diseases Clinical Research Network (RDCRN) - Autoimmunity, Rasmussen's, Inflammation & Status Epilepticus research Network (ARISEN)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Investigators with relevant expertise, especially Early-Stage Investigators (ESIs) as defined by NIH. Applicants already pursuing research topics within the ARISEN portfolio and newcomers to rare disease research with relevant expertise are eligible. Confirm the full requirements in the official notice before applying.
Rare Disease Pilot Grants and Other Requests for Applications (ARISEN Pilot Research Grant) is funded by Rare Diseases Clinical Research Network (RDCRN) - Autoimmunity, Rasmussen's, Inflammation & Status Epilepticus research Network (ARISEN). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
On June 2, 2026, the Department of Energy's Office of Critical Minerals and Energy Innovation selected two demonstration-scale facilities — Phoenix Tailings (with MIT and the University of Minnesota) for $66 million, and the Colorado School of Mines (with ElementUSA, PNNL, Principal Mineral, and Rare Earth Technologies Inc.) for the balance — under the Rare Earth Elements Demonstration Facility Program. Both projects pull rare earths from industrial waste — red mud at the Gramercy refinery in Louisiana, and a mix of mine and refining tailings elsewhere. Here is what the selections tell researchers, small businesses, and downstream magnet customers about where DOE thinks the chokepoint actually is, and what to do before the next demonstration-scale solicitation opens.
Read articlePAR-26-042 funds NLM-priority clinical informatics R01 grants up to $250,000 in direct costs per year through March 6, 2029, with standard NIH cycles on October 5, February 5, and June 5. The notice explicitly defines non-responsive applications: incremental tool improvements, projects primarily focused on social determinants of health, and projects primarily focused on ethical/legal/social issues. With NIH SBIR/STTR just reopened and the OMB Uniform Grants Regulation rewrite reshaping discretionary awards, the NLM clinical informatics line is one of the few stable, well-defined biomedical funding streams left at the agency. Here is how to read it.
Read articleOn May 19, the Department of Energy's Office of Critical Minerals and Energy Innovation announced 19 selections under FOA 3105 — two pilot-scale facilities for magnesium and rare-earth separation, and 17 technology development projects spanning lithium, cobalt, nickel, graphite, silicon, and manganese. Here is what the selection list tells researchers and small businesses about where DOE wants the supply chain in 18 months — and where the next solicitations will go.
Read article